Industry Briefs: Apr. 30, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: Apr. 30, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

AMRI has launched Smartsourcing sourcing options for its contract manufacturing and research services. Read More

AstraZeneca and The Medicines Company have entered into a global development and commercialization pact and have agreed to copromote Brilinta (ticagrelor), for treating acute ischaemic heart disease, in the United States. Read More

Baxter International has completed its purchase of Sigma International. Read More

Cetero Research has reached a final resolution with FDA over studies the company conducted in its Houston, Texas, bioanalytical laboratory between Apr. 1, 2005 through June 15, 2010. Read More

Covance and BML are expanding the companies’ jointly owned clinical-trial laboratory in Japan. Read More

GlaxoSmithKline and the University of Nottingham are collaborating to create a Center of Excellence for sustainable chemistry. Read More

Penn Pharma has invested in additional clinical and commercial packing capabilities. Read More

Teva has settled its patent-infringement litigation with Mylan in regards to Teva’s wakefulness product Nuvigil (armodafinil). Read More

Therapure has opened a custom biologics manufacturing facility. Read More

People News

AMRI has appointed Saravanakumar Dhakshinamoorthy as director of in vitro biology. Dhakshinamoorthy will report to Takeshi Yura, senior director of AMRI’s Singapore division. Read More

Watson Pharmaceuticals has announced changes in the company’s senior leadership. Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here